Liver cancer, Secondary cancers
Open
Phase 1
This trial is looking at BAY 3547926 on its own for liver cancer. It is also looking at adding it to .
This trial is for people:
who have a type of liver cancer called hepatocellular carcinoma (HCC) and
whose cancer has spread into surrounding tissues, to another part of the body or it isn’t possible to treat it with surgery
Recruitment start: 31 March 2025
Recruitment end: 30 July 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr David Pinato
Bayer
Last reviewed: 20 Nov 2025
CRUK internal database number: 20066